The COVID Antiviral Pill Could Pull Hospitals Back From the Brink

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on pocket
Pocket
Share on whatsapp
WhatsApp
The COVID Antiviral Pill Could Pull Hospitals Back From the Brink

Good news, maybe. There’s finally a pill for COVID—and it seems to work pretty well.

Molnupiravir, a co-development of New Jersey-based Merck and Ridgeback Biotherapeutics in Florida, is the first COVID antiviral medication in pill form. Merck and Ridgeback plan to submit their data to the FDA for possible authorization, though it’s unclear how quickly the agency might act. The FDA didn’t immediately respond to a request for comment.

Taken orally, the drug appears to halve the risk of hospitalization and slash the risk of death from serious COVID. “I’m pretty excited about these results,” Leila Hojat, an expert in infectious diseases at University Hospitals in Cleveland, told The Daily Beast.

Read More

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on pocket
Pocket
Share on whatsapp
WhatsApp

Never miss any important news. Subscribe to our newsletter.

Leave a Reply

Your email address will not be published.

Receive the latest news

Subscribe To Our Weekly Newsletter

Get notified about new articles